{"id":556,"external_id":"plugin_asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6","name":"app-69fdb4eb74f08191a3deeac63eb3a0f6","display_name":"Amass","developer":"Amass Technologies ApS","category":"Education & Research","listing_language":"en","listing_language_details":{"method":"cld-0.13.0/listing-v1","reliable":true,"detected_at":"2026-10-01T13:21:52Z","input_sha256":"bb81b1bd9434d1b7051afc18fb9e603775a1f596f5c275398bb9e3ed47707757","source_fields":["release.description","release.interface.short_description","release.interface.long_description"]},"version":"7.0.0","skill_count":0,"first_seen_at":"2026-09-30T22:02:35.000Z","last_seen_at":"2026-10-02T06:00:01.935Z","last_changed_at":"2026-09-30T22:02:35.000Z","install_count":null,"research_summary":null,"research_reviewed_at":null,"metadata":{"id":"plugin_asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6","name":"app-69fdb4eb74f08191a3deeac63eb3a0f6","scope":"GLOBAL","status":"ENABLED","release":{"id":"pluginrel_98cc90d7e4a8819190e8d9db9be38d26","skills":[],"app_ids":["asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6"],"version":"7.0.0","keywords":[],"interface":{"category":"Education & Research","logo_url":"https://files.openai.com/content?id=file_00000000cad8821098365992fb3607d8","brand_color":null,"website_url":"https://amass.tech","capabilities":[],"logo_url_dark":"https://files.openai.com/content?id=file_0000000039b8820a9450b3dca0ffd8a0","default_prompt":"Map the current landscape for oral GLP-1 agonists in obesity — what's approved, what's in trials, and who holds patents.","developer_name":"Amass Technologies ApS","default_prompts":["Map the current landscape for oral GLP-1 agonists in obesity — what's approved, what's in trials, and who holds patents.","Make the case for and against KRAS G12D as a drug target: biology, what's been tried clinically, and failures.","What happened to semaglutide since first approval — indication expansions, label changes, safety signals, and literature."],"screenshot_urls":[],"long_description":"Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.","composer_icon_url":"https://files.openai.com/content?id=file_0000000084a881f4903772380497f121","short_description":"Life sciences intelligence","plugin_category_id":"education & research","privacy_policy_url":"https://amass.tech/legal/privacy-policy","terms_of_service_url":"https://amass.tech/legal/terms-of-service","composer_icon_dark_url":"https://files.openai.com/content?id=file_0000000084a881f4903772380497f121"},"description":"Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.","app_manifest":{"apps":{"app-69fdb4eb74f08191a3deeac63eb3a0f6":{"id":"asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6","required":true}}},"display_name":"Amass","app_templates":[],"onboarding_skill_name":null,"requires_local_executor":false},"created_at":"2026-06-04T16:40:35.560229Z","is_template":false,"connector_id":"asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6","discoverability":"LISTED","canonical_app_id":"asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6"},"research":null,"package_metadata":{"name":"app-69fdb4eb74f08191a3deeac63eb3a0f6","author":{"name":"Amass Technologies ApS"},"sources":[{"path":".codex-plugin/plugin.json","sha256":"fa6e22bbd4085fb585d0f2c0dffcd3df54c93da34a075770aa90572c32c92f16"}],"version":"7.0.0","artifact_id":7093,"observed_at":"2026-10-02T00:06:16Z","support_url":"https://amass.tech/contact","field_sources":{"name":0,"author":0,"version":0,"support_url":0},"extraction_version":1,"conflicts_or_errors":[]}}